Table of Contents
1. Research Framework
1.1. Research Objective
1.2. Product Overview
1.3. Market Segmentation
2. Executive Summary
3. Global In-Situ Hybridization Market Insights
3.1. Industry Value Chain Analysis
3.2. DROC Analysis
3.2.1. Growth Drivers
3.2.1.1. Growing Prevalence of Target Disorders
3.2.1.2. Rising R&D Investments in In-Vitro Diagnostics
3.2.2. Restraints
3.2.2.1. Presence of an Ambiguous Regulatory Framework
3.2.3. Opportunities
3.2.3.1. Growing Awareness About the In-Situ Hybridization Usage
3.2.4. Challenges
3.2.4.1. Highly Skilled Labor-Intensive Product
3.3. Technology Advancements/Recent Developments
3.4. Regulatory Framework
3.5. Porter's Five Forces Analysis
3.5.1. Bargaining Power of Suppliers
3.5.2. Bargaining Power of Buyers
3.5.3. Threat of New Entrants
3.5.4. Threat of Substitutes
3.5.5. Intensity of Rivalry
4. Global In-Situ Hybridization Market Overview
4.1. Market Size & Forecast, 2019-2029
4.1.1. By Value (USD Million)
4.2. Market Share & Forecast
4.2.1. By Technology
4.2.1.1. Fluorescent In-Situ Hybridization (FISH)
4.2.1.2. Chromogenic In-Situ Hybridization (CISH)
4.2.2. By Probe
4.2.2.1. DNA
4.2.2.2. RNA
4.2.3. By Product
4.2.3.1. Instruments
4.2.3.2. Kits & Probes
4.2.3.3. Software
4.2.3.4. Services
4.2.4. By Application
4.2.4.1. Cancer
4.2.4.2. Cytogenetics
4.2.4.3. Developmental Biology
4.2.4.4. Infectious Diseases
4.2.4.5. Others
4.2.5. By End Use
4.2.5.1. Research & Diagnostic Laboratories
4.2.5.2. CROs
4.2.5.3. Academic Institutes
4.2.5.4. Others
4.2.6. By Region
4.2.6.1. North America
4.2.6.2. Europe
4.2.6.3. Asia Pacific (APAC)
4.2.6.4. Latin America (LATAM)
4.2.6.5. Middle East and Africa (MEA)
5. North America In-Situ Hybridization Market
5.1. Market Size & Forecast, 2019-2029
5.1.1. By Value (USD Million)
5.2. Market Share & Forecast
5.2.1. By Technology
5.2.2. By Probe
5.2.3. By Product
5.2.4. By Application
5.2.5. By End Use
5.2.6. By Country
5.2.6.1. United States
5.2.6.1.1. By Technology
5.2.6.1.2. By Probe
5.2.6.1.3. By Product
5.2.6.1.4. By Application
5.2.6.1.5. By End Use
5.2.6.2. Canada
5.2.6.2.1. By Technology
5.2.6.2.2. By Probe
5.2.6.2.3. By Product
5.2.6.2.4. By Application
5.2.6.2.5. By End Use
6. Europe In-Situ Hybridization Market
6.1. Market Size & Forecast, 2019-2029
6.1.1. By Value (USD Million)
6.2. Market Share & Forecast
6.2.1. By Technology
6.2.2. By Probe
6.2.3. By Product
6.2.4. By Application
6.2.5. By End Use
6.2.6. By Country
6.2.6.1. Germany
6.2.6.1.1. By Technology
6.2.6.1.2. By Probe
6.2.6.1.3. By Product
6.2.6.1.4. By Application
6.2.6.1.5. By End Use
6.2.6.2. United Kingdom
6.2.6.2.1. By Technology
6.2.6.2.2. By Probe
6.2.6.2.3. By Product
6.2.6.2.4. By Application
6.2.6.2.5. By End Use
6.2.6.3. Italy
6.2.6.3.1. By Technology
6.2.6.3.2. By Probe
6.2.6.3.3. By Product
6.2.6.3.4. By Application
6.2.6.3.5. By End Use
6.2.6.4. France
6.2.6.4.1. By Technology
6.2.6.4.2. By Probe
6.2.6.4.3. By Product
6.2.6.4.4. By Application
6.2.6.4.5. By End Use
6.2.6.5. Spain
6.2.6.5.1. By Technology
6.2.6.5.2. By Probe
6.2.6.5.3. By Product
6.2.6.5.4. By Application
6.2.6.5.5. By End Use
6.2.6.6. Belgium
6.2.6.6.1. By Technology
6.2.6.6.2. By Probe
6.2.6.6.3. By Product
6.2.6.6.4. By Application
6.2.6.6.5. By End Use
6.2.6.7. Russia
6.2.6.7.1. By Technology
6.2.6.7.2. By Probe
6.2.6.7.3. By Product
6.2.6.7.4. By Application
6.2.6.7.5. By End Use
6.2.6.8. The Netherlands
6.2.6.8.1. By Technology
6.2.6.8.2. By Probe
6.2.6.8.3. By Product
6.2.6.8.4. By Application
6.2.6.8.5. By End Use
6.2.6.9. Rest of Europe
6.2.6.9.1. By Technology
6.2.6.9.2. By Probe
6.2.6.9.3. By Product
6.2.6.9.4. By Application
6.2.6.9.5. By End Use
7. Asia-Pacific In-Situ Hybridization Market
7.1. Market Size & Forecast, 2019-2029
7.1.1. By Value (USD Million)
7.2. Market Share & Forecast
7.2.1. By Technology
7.2.2. By Probe
7.2.3. By Product
7.2.4. By Application
7.2.5. By End Use
7.2.6. By Country
7.2.6.1. China
7.2.6.1.1. By Technology
7.2.6.1.2. By Probe
7.2.6.1.3. By Product
7.2.6.1.4. By Application
7.2.6.1.5. By End Use
7.2.6.2. India
7.2.6.2.1. By Technology
7.2.6.2.2. By Probe
7.2.6.2.3. By Product
7.2.6.2.4. By Application
7.2.6.2.5. By End Use
7.2.6.3. Japan
7.2.6.3.1. By Technology
7.2.6.3.2. By Probe
7.2.6.3.3. By Product
7.2.6.3.4. By Application
7.2.6.3.5. By End Use
7.2.6.4. South Korea
7.2.6.4.1. By Technology
7.2.6.4.2. By Probe
7.2.6.4.3. By Product
7.2.6.4.4. By Application
7.2.6.4.5. By End Use
7.2.6.5. Australia & New Zealand
7.2.6.5.1. By Technology
7.2.6.5.2. By Probe
7.2.6.5.3. By Product
7.2.6.5.4. By Application
7.2.6.5.5. By End Use
7.2.6.6. Indonesia
7.2.6.6.1. By Technology
7.2.6.6.2. By Probe
7.2.6.6.3. By Product
7.2.6.6.4. By Application
7.2.6.6.5. By End Use
7.2.6.7. Malaysia
7.2.6.7.1. By Technology
7.2.6.7.2. By Probe
7.2.6.7.3. By Product
7.2.6.7.4. By Application
7.2.6.7.5. By End Use
7.2.6.8. Singapore
7.2.6.8.1. By Technology
7.2.6.8.2. By Probe
7.2.6.8.3. By Product
7.2.6.8.4. By Application
7.2.6.8.5. By End Use
7.2.6.9. Vietnam
7.2.6.9.1. By Technology
7.2.6.9.2. By Probe
7.2.6.9.3. By Product
7.2.6.9.4. By Application
7.2.6.9.5. By End Use
7.2.6.10. Rest of APAC
7.2.6.10.1. By Technology
7.2.6.10.2. By Probe
7.2.6.10.3. By Product
7.2.6.10.4. By Application
7.2.6.10.5. By End Use
8. Latin America In-Situ Hybridization Market
8.1. Market Size & Forecast, 2019-2029
8.1.1. By Value (USD Million)
8.2. Market Share & Forecast
8.2.1. By Technology
8.2.2. By Probe
8.2.3. By Product
8.2.4. By Application
8.2.5. By End Use
8.2.6. By Country
8.2.6.1. Brazil
8.2.6.1.1. By Technology
8.2.6.1.2. By Probe
8.2.6.1.3. By Product
8.2.6.1.4. By Application
8.2.6.1.5. By End Use
8.2.6.2. Mexico
8.2.6.2.1. By Technology
8.2.6.2.2. By Probe
8.2.6.2.3. By Product
8.2.6.2.4. By Application
8.2.6.2.5. By End Use
8.2.6.3. Argentina
8.2.6.3.1. By Technology
8.2.6.3.2. By Probe
8.2.6.3.3. By Product
8.2.6.3.4. By Application
8.2.6.3.5. By End Use
8.2.6.4. Peru
8.2.6.4.1. By Technology
8.2.6.4.2. By Probe
8.2.6.4.3. By Product
8.2.6.4.4. By Application
8.2.6.4.5. By End Use
8.2.6.5. Rest of LATAM
8.2.6.5.1. By Technology
8.2.6.5.2. By Probe
8.2.6.5.3. By Product
8.2.6.5.4. By Application
8.2.6.5.5. By End Use
9. Middle East & Africa In-Situ Hybridization Market
9.1. Market Size & Forecast, 2019-2029
9.1.1. By Value (USD Million)
9.2. Market Share & Forecast
9.2.1. By Technology
9.2.2. By Probe
9.2.3. By Product
9.2.4. By Application
9.2.5. By End Use
9.2.6. By Country
9.2.6.1. Saudi Arabia
9.2.6.1.1. By Technology
9.2.6.1.2. By Probe
9.2.6.1.3. By Product
9.2.6.1.4. By Application
9.2.6.1.5. By End Use
9.2.6.2. UAE
9.2.6.2.1. By Technology
9.2.6.2.2. By Probe
9.2.6.2.3. By Product
9.2.6.2.4. By Application
9.2.6.2.5. By End Use
9.2.6.3. Qatar
9.2.6.3.1. By Technology
9.2.6.3.2. By Probe
9.2.6.3.3. By Product
9.2.6.3.4. By Application
9.2.6.3.5. By End Use
9.2.6.4. Kuwait
9.2.6.4.1. By Technology
9.2.6.4.2. By Probe
9.2.6.4.3. By Product
9.2.6.4.4. By Application
9.2.6.4.5. By End Use
9.2.6.5. South Africa
9.2.6.5.1. By Technology
9.2.6.5.2. By Probe
9.2.6.5.3. By Product
9.2.6.5.4. By Application
9.2.6.5.5. By End Use
9.2.6.6. Nigeria
9.2.6.6.1. By Technology
9.2.6.6.2. By Probe
9.2.6.6.3. By Product
9.2.6.6.4. By Application
9.2.6.6.5. By End Use
9.2.6.7. Algeria
9.2.6.7.1. By Technology
9.2.6.7.2. By Probe
9.2.6.7.3. By Product
9.2.6.7.4. By Application
9.2.6.7.5. By End Use
9.2.6.8. Rest of MEA
9.2.6.8.1. By Technology
9.2.6.8.2. By Probe
9.2.6.8.3. By Product
9.2.6.8.4. By Application
9.2.6.8.5. By End Use
10. Competitive Landscape
10.1. List of Key Players and Their Offerings
10.2. Global In-Situ Hybridization Company Market Share Analysis, 2022
10.3. Competitive Benchmarking, By Operating Parameters
10.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)
11. Impact of Covid-19 on Global In-Situ Hybridization Market
12. Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT Analysis)
12.1. Thermo Fisher Scientific Inc.
12.2. Abbott (Abbott Molecular)
12.3. PerkinElmer, Inc.
12.4. BioView
12.5. Agilent Technologies, Inc.
12.6. Merck KGaA
12.7. Bio-Rad Laboratories, Inc.
12.8. Oxford Gene Technology IP Limited
12.9. Leica Biosystems Nussloch GmbH
12.10. F. Hoffman-La Roche Limited
12.11. NeoGenomics Laboratories, Inc.
12.12. Advanced Cell Diagnostics, Inc.
12.13. Other Prominent Players
13. Key Strategic Recommendations
14. Research Methodology
14.1. Qualitative Research
14.1.1. Primary & Secondary Research
14.2. Quantitative Research
14.3. Market Breakdown & Data Triangulation
14.3.1. Secondary Research
14.3.2. Primary Research
14.4. Breakdown of Primary Research Respondents, By Region
14.5. Assumptions & Limitations